Literature DB >> 2122898

Hepatic drug conjugation/deconjugation systems in hepatosplenic schistosomiasis.

M el Mouelhi1, M M Mansour.   

Abstract

The biotransformation capacity of the liver is altered in hepatosplenic schistosomiasis being more in favor of deconjugation pathways. These alterations should be considered when xenobiotics are administered and in studies of hepatic toxicity and carcinogenicity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2122898     DOI: 10.1016/0006-2952(90)90375-u

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  3 in total

1.  Propolis enhances the effectiveness of praziquantel in experimental schistosomiasis: biochemical and histopathological study.

Authors:  Tamer Y Mahmoud; Sherine M Rizk; Amany S Maghraby; Amira A Shaheen
Journal:  Parasitol Res       Date:  2014-10-01       Impact factor: 2.289

Review 2.  Relationship between schistosomiasis and bladder cancer.

Authors:  M H Mostafa; S A Sheweita; P J O'Connor
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

Review 3.  Glucuronidation of drugs. A re-evaluation of the pharmacological significance of the conjugates and modulating factors.

Authors:  H K Kroemer; U Klotz
Journal:  Clin Pharmacokinet       Date:  1992-10       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.